Skip to main content

Phase 3 clinical trial of COVAXIN shows 81 per cent efficacy: Bharat Biotech

The phase 3 clinical trial was jointly initiated by ICMR and Bharat Biotech International Limited in mid-November 2020. The trial has been conducted on a total of 25,800 individuals across 21 sites.


Popular posts from this blog

Parliamentary panel on Information Technology summons Facebook, Google on June 29

India’s Permanent Mission at the United Nations, on June 20, 2021, had clarified that the new Information Technology rules introduced by India have been ‘designed to empower the ordinary users of social media'. source